Oncotype Dx Test Anyone?
Comments
-
When I was first informed about the oncotype test and it's purpose, I found it disquieting. The fact that I could have a cancer for which no known chemo would kill without whose side effects were worse, was NOT comforting. Wouldn't it be better if chemos were beneficial to all and were in everyone's tool box? Chemo doesn't scare me...not having a chemo that benefits me is much more scary. I'm not suggesting that everyone do chemo...I am suggesting that we find more effective therapies. I did chemo for a chance at a cure. If I had an oncotype of 17 or lower, I would still have a risk of distant recurrence with no statistical chemo option to reduce the risk. I would not have done a "no chemo happy dance". If tailorx shows that more women should forego chemo because it really isn't worth it, I think that is just plain sad.
MsP
-
MsPharoah, I think the challenge with chemo is creating a tool, if you will, that is as tailored to each person's disease, to achieve the best possible outcome. For many of us our cancer will never recur - locally or distant - whether we do chemo or not. There is no guarantee and no real way to predict who will recur - we can only guesstimate based on the science in front of us. The Oncotype test has been a godsend, I'm sure for many of us as we try to weigh data gleaned over decades - good data, to be sure, but it's not us, it's not personal. The Oncotype test IS personal - it tells me about MY cancer, not cancer in general. In my case, the Oncotype test made all the difference in the world - it gave me something definitive to hold on to, to believe in, to trust. It wasn't nebulous or generic - it was very specific, and felt very personal.
Before my test results, my onc suggested 6xTC, "but we'll be happy if you can complete 4." This decision was based primarily on my tumor size (1.3 cm), and the location of the tumor (against the chest wall in the inner-upper quad). Had my test come back lower than 20, I wasn't sure I was going to do chemo, frankly - the SEs and risk didn't seem to outweigh the benefit, given that I thought I had a pretty "easy" early-stage cancer. So did my doctor. Once the test came back, treatment changed significantly because my cancer required stronger chemo. Without the test, I might have chosen no chemo, or chosen to try 4xTC (and given up on the final two because, well, my onc didn't seem to think it was *that* necessary). In the end, however, even chemo is not a "cure" - without Tamoxifen my recurrence rate (with chemo) has been reduced to something like 25%.
On the flip side of that is the possibility for those to have very low Oncotype scores - their cancer does not require chemo and in fact chemo could do more harm than good. Sometimes, I wish I'd been given the option to do the "no chemo happy dance" and not be dealing with the long-term side effects that chemo has blessed me with. There's a trade-off in every decision we make; I think the Oncotype test is giving more personalized options in this battle we fight, and I hope and pray that it continues to be refined so that fewer women who don't need chemo are having it, and those who really do need it are getting it.
-
My onc did say that if the Oncotype Dx wasn't available I would be a no chemo recommendation. This may well change it.
-
Perhaps I have been misunderstood. I consider the oncotype test to be additional data that we use to make decisions. So thats a good thing. But take a look at the relative benefits of chemo in the intermediate zone. If tailorx shows less benefit at a higher score, is that a good thing? I don't think so unless it also lowers the recurrence rate and there is no reason to believe that tailorx will do that. Am I wrong? If tailorx finds that my intermediate 24 is now in the low category.....will it also tell me my recurrence score is lower? If not then telling me that chemo is of less value is not a happy story for me or for anyone with a score of 24 in the future.
MsP
-
MsP - I share the concern that there are a group of use with an uncomfortably high recurrence risk who current treatments may not benefit and they simply don't have a better plan at this point. And so we go with the chemo simply because we don't know what else to do.
-
I'm sorry if I misunderstood you, MsPharaoh - I certainly didn't mean to imply anything with my response, either. I am highly protective (??) of the Oncotype test because of how it turned out for me. Scares the crap outta me, to be honest, so I kinda hate it, too. :-) But it gave me such good information that I otherwise didn't have. And I've read/participated in conversations here with women who wanted - practically begged - for chemo because they wanted to "throw everything at it," when their diagnosis and Oncotype test did not warrant such drastic treatment. It's very difficult emotionally to explain to another warrior that the Gold Standard of Treatment would actually be of harm, rather than benefit, in their particular case. If your score comes back as 2 or 3, you might feel comfortable saying, "Okay, I can forgo this." But what about when it's 11 or 14 - do you start to feel like it's the "high end" of low risk? Or 17 or 18 - too close to intermediate to ignore? That dreaded "grey area" seems to bleed into both the low- and high-risk areas very easily, depending on oncologists - and a patient's fears. As someone living with cancer, every choice we make could determine our future, so why wouldn't we want to do everything we can to ensure our longevity?
My hope is that research continues so that that "grey area" disappears one day, and there is a definitive cut-off for when chemo is beneficial, and when it is more harmful than good. Until then, I wish everyone (and you, too, Warrior Woman!) a definitive score one way or another.
-
Sisters...worrying that chemo wouldn't offer additional protection if TailorX proves that those with intermediate scores are moved to the low risk category is no different than taking a statin for heart disease for most people. Follow me with this idea. As you are probably aware, there were new guidelines for statins issued a few weeks ago. Once they were published the you know what hit the fan! Harvard trained and professor John Abramson, MD, wrote a critical reaction to the guidelines. In a book written a few years ago, he questioned the use of statins by so many people. I highly recommend reading his book as well, Overdosed America. Now, one of the lightening points of Dr. Abramson is that aside from primary use of statins for those who have previously had a heart attack and for those at truly high risk of having a heart attack, statins will save very few other lives. And, we still have no explanation why so many people who have normal cholesterol numbers, eat well, are not diabetic, have normal blood pressure STILL develop heart disease. So it is an equally sobering point that there is a treatment out there, a statin, much like chemo, that might not reduce one's risk of getting a potentially fatal disease. Frustrating? Yes! But we do have cause to be hopeful. Because if you read Eric Topol, MD's book, The Creative Destruction of Medicine, you will see how we are moving towards a more individualized type of research and treatment of disease. Ultimately, we will no longer have such long and largely populated trials that yield little info on what is the best treatment. So while we may be frustrated now, there are glimpses of what we will be doing in the coming decade that will please many of us. The sobering thought today is that medicine claims to offer so many treatments for so many diseases, but the fact remains that we never know in most cases with certainty who can benefit the most or least from any one treatment.
-
We are all looking for the "This is exactly what you need to do/take to live to a ripe old age and make your children miserable" speech. But in today's world, it will not come. I did the no chemo happy dance. Today - I second guess that decision a lot; I was an oncotype 18. Even a second opinion on the no chemo provides me with no comfort. Cancer is scary, I want to know I ( and every one on my medical team) gave it my all. The best I can hope for, is that the world will be different for my children. May they never have to worry about these things and may they not have my BRCA mutation. We are paving the road for those that follow in our footsteps.
-
That's precisely what I want, Bayoubabe. Even better, I want to stand in a machine that can screen me for everything and immediately resolve any disorders I am suffering from...including hangnails!
-
Yes, Warrior Woman! I've thought for many years that the medical world needed Tricorders, like in Star Trek. When my Oncotype score came back an 8 I was actually disappointed that I didn't need chemo - I was ready to tackle this thing with everything I had. But, everyone else around me was ecstatic I didn't need it.
-
Good evening all and a very Happy New Year for 2014, I guess I am reflecting on a lot this evening and would share this- we have a LOT to be thankful for- here we are in 2013 agonizing over the results of a test that didn't exist 20 years ago. We talk about to radiate, to not radiate, aromatase inhibitors, tamoxifen even sentinel node bx.
Back in the day if you were diagnosed with breast cancer you had a radical or maybe just maybe a modified radical- not a lot of decisions, not a lot of research and outcomes data just you, your surgeon and your breast building the data we use today.
I would end by saying this- a lot of time and effort is going into a study to see at what point chemo does or does not provide appreciable benefit- so the assumption is breast cancer itself is not cured we just get more refined at treating it.
I am not as optimistic as some of my fellow posters about the future of all this. I think that the changes to healthcare legislation a.k.a PPACA will stifle funding,research and the way we treat all illness and disease will change fundamentally in the next 5 years because healthcare as we know it will not exist.
-
I am one of the strong proponents of the Oncotype test and yes I did the happy no chemo dance. My Onc was ambivalent about my treatment plan. I had Stage 2(micromet in SN). Had lumpectomy. When Path report came back my BS was surprised, I was stunned. He said it would get me chemo; my Onc disagreed and ordered the test. My score came back 11; and my tumor was determined to be mon-aggressive. My recurrence is 8%. I am forever grateful for this test and I don't consider 11 to be in the gray area for a low score at all and neither did my Oncologist. I have seen a lady on this forum with a 0 score but very few 2 or 3 scores. Diane
-
I personally know a woman with a 0 score with a micromet (she doesn't post here). Sometimes I wonder if that score gives her a false sense of security as she refuses to do the hormone blockers (for all of the reasons we hate them). The recurrence %, that correlates to any of our scores, assumes we are doing Tamoxifen, so her 1% chance of recurrence increases to what??? without the blockers? I've seen as much as 30%, but I've seen others say a lot smaller number.
I know it is much much greater than chemo, no matter what Oncotype score one has.
-
I think the lowest recurrence is 4% , I know with a 3 mine is 4% and with a 1 it is also 4%. My onc said not doing hormonals based on the onco score alone is putting a lot of faith in one number. It will be interesting to see if things change in the future. Perhaps at some point the Oncotype test or similar test will be used to determine not only the need for chemo but the need for hormonals.
-
I wish to thank everyone who has posted on this thread. It has really helped me during this prolonged waiting period for my Oncotype score. Turns out they had to retest as they didn't have enough RNA but the results should be in by the end of this week. Whatever way it goes I do feel better prepared and grateful that you've held my hand. I wish everyone on here a 2014 that makes up in abundance what we've sacrificed in 2013 and before. Happy New Year friends!
-
I'm someone who has an Oncotype score of 0 which, according to the test results, puts my average rate of distant recurrence at 3%, provided I complete 5 years of hormonal therapy. Even though there's not a huge difference in that percentage if I were to opt out of taking my little white pill each day, I'm not willing to take that chance. I also completed almost seven weeks of radiation. I do NOT want this thing to return and any little bit I can throw at it, I will. Every single percentage point counts to me, and if somehow I do have a recurrence down the road I don't want to think, "If only I'd .... " While I'm very happy to not have to go through chemo, sometimes I wonder if I'm doing enough prevention-wise, but am really pretty much limited to the hormonals at this point. Well, that and the life-style changes--have gotten below a 25 bmi and am exercising, no alcohol, eating well, taking some supplements, etc. and those things are important too . . . but still there's a kind of comfort in taking something tangible, like my daily Arimidex. Luckily, I've had very few SEs with that, and radiation was pretty easy for me, too, so I feel blessed.
Anyway, I'm so very happy the test was available and spared me the chemo. (Now I just hope it's trustworthy!! There's always that little doubt.) Good luck to everyone waiting for their results.
And Happy New Year!
-
I wouldn't put all of your eggs on the oncotype. I got a 25 oncotype on my biopsy . I had a 3 in the lumpectomy and a high risk mammaprint. I think the heterogenousity of the tumor can make this scores different, unless you had a very small tumor , different parts can yield different scores.
-
Srh - My tumor was .6 cm and any smaller it would not have qualified for the Oncotype. For all the research I've done, they clearly feel it is the best instrument to date for measuring recurrence risk and chemo benefit. And still, questions loom. I had slight different pathology reports for my biopsy and surgery and I assume it was due to technician interpretation. However, the later gave me a clearly better prognosis. I would hope that Genomic does something to account for heterogeneity as that is clearly an issue. Fingers crossed.
-
Kam170, that's a really interesting point about your friend. I had actually been looking at it from the reverse standpoint.
While I would have done almost anything to be able to avoid chemo, with all the horror stuff I'd read about the hormone blocker SE's I could see why up to 1/3 of women, according to some studies, don't complete their prescribed course. (Or they do, and then it's like surprise, thanks for the 5 years, now give us another 5!) A little voice in the back of my head was whispering that If I got to a point where I needed to consider discontinuing hormone blockers to preserve QOL, would I want to feel like I couldn't, because I took a no-chemo route? E.g. that discontinuing hormone blockers would leave the fort entirely uncovered?
Before my SX, I was 100% convinced that Oncotype was going to be my ticket to a no-chemo happy dance. I researched it to death, although I hadn't found the predictor tool provided in this thread (cool! I'm a numbers person too.) Then at SX one of my sentinel nodes was positive, and not a micromet, which meant my insurance probably would not cover the test. So more research, and I was all set to ask to be signed up for the S1007 RxPONDER trial (1-3 positive nodes, Onco <25) as my avenue for getting the test. Of course, when my path report came back with 11 positive nodes on Dec 19, that all went out the window.
Still, I've been following this thread with great interest. I too am disappointed in the fact that even if the top end of the low risk range keeps moving up, from 12 to 18 and then maybe 24, what does that really buy us? An increased slice of the population won't benefit from chemo - okay, what does that tell us about the quality and efficacy of available chemo options? If everyone's biology is so individual, why does nearly everyone on these forums have the same 3-5 chemo regimens (mostly the same 1 or 2, for ER+/PR+/HER2-) with very little variation other than infusion frequency?
I don't mind admitting that I'm terrified of the upcoming chemo and, being a bit of a control freak, this entire diagnosis and all that comes with it has turned my world upside down. The BRCA2 positive result was a freak lightning bolt out of nowhere (the mutation was hiding on my dad's side), but at least it simplified the decision to take the BMX route. And the Stage IIIc finding was also very difficult to handle, still is, but again it takes the chemo / no chemo decision out of my hands and I won't be second-guessing myself.
Because ... when I used the Oncotype predictor spreadsheets, my result came out at 25-26. Smack in the middle of indeterminate! My tumor is Grade 3 and I might well have been beating myself up later on down the road if I didn't do chemo. (KI-67 is 30%, which is "high" though not by much.)
Sorry this ran long, and thanks for listening. I look forward to any perspectives in response, as this whole dialogue has been very educational. Happy New Year to all!
-
Paloverde - Here's where I am now based upon a long discussion with my Onc and my position is subject to change. If I am intermediate I will do the chemo because like many here, I too want to do all I can and not have regrets. If I am below 12 (unlikely) I won't do chemo. If I am between 12 - 18 I will look at the chart on page 2 of the report to determine the extent to which to chemo will lower my risk. 3% risk reduction or greater and I am doing chemo. 1% probably not. 2%...maybe not. Part of the reason for my decision is my high ki67 at 40% which is questioned because it doesn't fit with my overall profile. I don't have great confidence in the lab that reported it as they got another pathology report wrong. One small study said that it's the high ki67s that are the ones in the low RS who have recurrence. Other studies show that for women like myself with low mitotic scores (1) and high ki67s the mitotic scores clearly trump the ki67. In your situation there are too many risk factors that lean toward chemo. I really thought I would be positive for a BRCA mutation but I am not so they're doing the other BC genetic tests. I will be getting two different professional opinions before making a final chemo decision. We may be going through this together.
-
P.S. - I'm also the one who started the "How do they measure whether adjuvant chemo is working" thread, and as a scientific type, am not so thrilled about the realities there either!
-
Paloverde, hi! Your 4th paragraph expressed my thoughts and concerns so much better than I did in previous posts. Thank you for that. "what does that tell us about the quality and efficacy of current chemo options?". Indeed! For me, it was even more complicated. My tumor was lobular and had a low mitotic rate. All the research shows that chemo is less effective for lobular and slow growing cancer! Huh? So when I had my consultation with my onc and she recommended chemo, I told her that "if we are going to do chemo, let's make sure we don't just pi$$ off my cancer". I don't know if chemo did anything; nor does anyone, but I did it.
Once I made up my mind to do chemo, I was all in! I did well. I had some bad days, really tired, but I worked through the entire 18 weeks and maintained a pretty normal life..(which, btw, was much more healthful for me). Every time I saw my onc and she asked how I was doing, I repeated the same phrase.."I'm doing well!". I remember the shocked look on her face the first time! And when she sent me back for the next infusion, I always said..."let's kill some more cancer". I will tell you that they have learned a lot about how to manage side effects...nausea, low blood counts, etc. And you should hold your onc's feet to the fire to make sure you have minimal side effects. Yes, you will lose your hair, but that doesn't hurt, nor does it affect your health, really...what it does is possibly rob you of your privacy and send off "sick signals" that could mean you have to spend a lot of energy making other people feel ok. But they have fabulous wigs...I have 3 and quite honestly, i wish I could wear them forever...just might.
Best to you for minimal side effects and a healthful 2014 . Let's kill some cancer, hon!
MsP
-
In preparation I've looked into the cold caps. As sad as I will be to lose my hair, it does grow back. I am leaning away from cold caps as I don't want the extra layer of complication in my life. My husband keeps saying that the cancer treatment hasn't really changed in decades and we should just go back to blood letting and leaches. (That's a joke.)
-
That's funny, my husband said something similar - that in future generations, people will look back on today's ("3rd generation") chemo, call it primitive & barbaric and compare it to leeches!
-
I believe 0-17 scores are low scores so if my score had been 16 not 11 and the tumor was aggressive, which it was not, my Oncologist might have had a chemo treatment plan instead of 33 RADS. Just glad that I didn't have to make that call.
-
I escaped the rads when they chopped my boobs off.
-
I find this thread is fascinating and you all have such great things to say. I'm learning a lot from you all. I do wonder (and I'm sure this info. can be found somewhere - I just haven't located it yet) if Oncotype takes into account age? I'm 36 and I did the prediction model posted earlier in this thread and I was a 26. I have a Ki-67 of 40%, so my guess that if I truly am in the gray zone, I will definitely be in the higher end of it. I just wonder if age plays a factor, if not for Oncotyping, but generaly wiht MO recommendations.
-
Hi Graceber,
Most oncologists will take age into consideration. As a young woman, you have a lot of living to do and so there are many more years you need to be cancer free. Also, the younger you are, it is presumed that you are more healthy and can take a harsher treatment. These generalizations are not always true, but they are considerations. Good luck, hon!
MsP
-
Just for information, the "high" cutoff for Ki67 is 12-13%. I've seen both figures, 12 and 13. I happened upon my Ki67 when going over initial pathology reports, between BMX and receiving my oncotype score. "Ki67 60% - poor prognosis" Boy, did that get my heart pounding. My NCI treatment center did not do Ki67 - the nurse coordinator quoting the pathologist "that test is unreliable," trying to calm me down, I think. I have read that it is a hard test to reproduce, lab to lab, but it is one of the handful of markers that Geonomics uses to to determine the proliferation factor in the Oncotype score. I'm sure that 60% contributed to my high Oncotype score, as well as my low PR, though still slightly positive.
-
If I were over 100 years old I'd skip chemo but I'd still want the boob job. LOL
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team